Skip to content

Traditional invasive versus minimally invasive esophagectomy.

Traditional invasive vs. minimally invasive esophagectomy: a multi-centered, randomized trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON20420
Enrollment
160
Registered
2010-08-02
Start date
2009-06-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

oesophagectomy, minimally invasive, open, cancer

Interventions

Comparison between traditional open and minimally invasive transthoracic resection for oesophageal cancer.

Sponsors

VU university medical center
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Histologically proven squamous cell carcinoma, adenocarcinoma or undifferentiated carcinoma of the intrathoracic oesophagus and Siewert I junction tumors which are surgically resectable (T1-3, N0-1, M0); 2. Treatment with neo-adjuvant therapy; 3. Age of the patients must be ≥ 18 and ≤ 75 years; 4. European Clinical Oncology Group (ECOG) performance status of 0, 1 or 2; 5. Written informed consent.

Exclusion criteria

Exclusion criteria: 1. Carcinoma of the cervical oesophagus; 2. Prior thoracic surgery; 3. No informed consent is provided.

Design outcomes

Primary

MeasureTime frame
Respiratory complications (infections) within two weeks after the operation.

Secondary

MeasureTime frame
1. Operation related events (e.g. duration of operation, blood-loss); 2. Re-operations; 3. General morbidity (major and minor); 4. Length of ICU and hospital stay (days); 5. Type and number of analgesics needed after operation; 6. VAS-pain-score; 7. Return to fluid and normal diet; 8. Quality of life questionnaires (SF-36 and EORTC QLQ-OES18); 9. Quality of the specimen resected (e.g. length of specimen, number and location of lymph nodes resected and circumferential resection margin); 10. Hospital mortality; 11. Readmissions; 12. Survival.

Contacts

Public ContactS.S.A.Y. Biere

De Boelelaan 1117

s.biere@vumc.nl+31 (0)20 4444444

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)